Meige Syndrome with Apraxia of Lid Opening after the Discontinuation of Sulpiride Treatment

We report a case of Meige syndrome with apraxia of lid opening that lasted for about seven months after discontinuation of sulpiride treatment. To our knowledge, this is the first report demonstrating that Meige syndrome with apraxia of lid opening is induced by sulpiride, and that the condition persists.

References

• 1 Ananth J, Edelmuth E, Dargan B. Meige’s syndrome associated with neuroleptic treatment.  Am J Psychiatry. 1988;  145 513-515
• 2 Boghen D. Apraxia of lid opening: a review.  Neurology. 1997;  48 1491-1494
• 3 Casey D E. Pharmacology of blepharospasm-oromandibular dystonia syndrome.  Neurology. 1980;  30 690-695
• 4 Farde L, Nordstrom A L. PET analysis indicates atypical central dopamine receptor occupancy in clozapine-treated patients.  Br J Psychiatry Suppl. 1992;  17 30-33
• 5 Hayashi T, Furutani M, Taniyama J, Kiyasu M, Hikasa S, Horiguchi J J. et al . et alNeuroleptic-induced Meige’s syndrome following akathisia: pharmacologic characteristics.  Psychiatry Clin Neurosci. 1998;  52 445-448
• 6 Kebabian J W, Calne D B. Multiple receptors for dopamine.  Nature. 1979;  277 93-96
• 7 Meige H. Les convulsions de la face, une forme clinique de convulsion faciale, bilaterale et médiane.  Revue Neurologique. 1910;  20 437-443
• 8 Miller L G, Jankovic J. Sulpiride-induced tardive dystonia.  Mov Disord. 1990;  5 83-84
• 9 Moore S, Kenyon P. Atypical antipsychotics, clozapine and sulpiride do not antagonise amphetamine-induced stereotyped locomotion.  Psychopharmacology (Bed). 1994;  114 123-130
• 10 Seeman P, Corbett R, Van Tol H H. Atypical neuroleptics have low affinity for dopamine D2 receptors or are selective for D4 receptors.  Neuropsychopharmacology. 1997;  16 93-110; discussion 1 - 35
• 11 Stahl S M. Conventional Neuroleptic Drugs for Schizophrenia and Novel Antipsychotic Agents.  Essential Psychopharmacology. United Kingdom; CAMBRIDGE UNIVERSITY PRESS 1996: p.270
• 12 Stahl S M, Yesavage J A, Berger P A. Pharmacologic characteristics of Meige dystonia: differentiation from tardive dyskinesia.  J Clin Psychiatry. 1982;  43 445-446
• 13 Tamminga C A, Gerlach J. New neuroleptics and experimental antipsychotics in schizophrenia.  in Psychopharmacology, The third generation of progress. ed. by Meltzer HY New York; Raven Press 1987: p. 1129-1140
• 14 Tanner C M, Glantz R H, Klawans H L. Meige disease: acute and chronic cholinergic effects.  Neurology. 1982;  32 783-785
• 15 Tolosa E S, Lai C. Meige disease: striatal dopaminergic preponderance.  Neurology. 1979;  29 1126-1130
• 16 Weiner W J, Nausieda P A, Glantz R H. Meige syndrome (blepharospasm-oromandibular dystonia) after long-term neuroleptic therapy.  Neurology. 1981;  31 1555-1556